InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Ubertino post# 716

Friday, 07/25/2014 3:50:45 PM

Friday, July 25, 2014 3:50:45 PM

Post# of 6725
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold

http://www.marketwatch.com/story/tekmira-provides-update-on-tkm-ebola-phase-i-clinical-hold-2014-07-21

Tekmira Pharmaceuticals Corporation TKMR +2.10% CA:TKM +1.30% , a leading developer of RNA interference (RNAi) therapeutics, today announced an update on the TKM-Ebola Phase I clinical hold. The Company has received the clinical hold letter from the U.S. Food and Drug Administration (FDA) and is preparing a Complete Response to the Agency. The Company anticipates this matter will be resolved by Q4, 2014.







In Reply to 'nanopatent'
If this takes longer than a week to settle I'll be angry!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News